United States trade policy undermines access to anti-retroviral medicines
23 July 2012
We collect analytics data in order to understand site usage. This data is collected anonymously and is not associated to you personally. Decide what you want to share with us below.
Despite commitment to end AIDS, the US government is introducing stronger intellectual property rules through trade agreements and bilateral pressure that will undermine the fight against AIDS by devastating the ability of developing countries to access affordable anti-retroviral medicines.